The aim of MAPPs is to enable quicker access for patients whilst providing adequate and evolving evi...
Read moreBased on the current clinical data, the PCSK9 inhibitors are a vital new treatment option for patien...
Read moreIncluded is the P&R challenges faced by the PCSK9 inhibitors as well as how payers are trying to ove...
Read moreIt is the responsibility of CCGs to manage their local drug budgets
Read moreThis article contains official prices at the ex-manufacturer, wholesaler and pharmacy selling price ...
Read moreThe proposal states that the CDF should become a "managed access" fund for new cancer dugs, with cle...
Read moreIn this issue is an overview of the future changes to the UK Cancer Drug Fund as well as approaches ...
Read morePharmaceutical companies are now launching curative treatments, in addition to drugs which only mana...
Read moreNHS England have recently proposed that NICE should take a more direct role in determining which pro...
Read moreAn update on UK market access at EUCOPE meeting
Read more